BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 240 filers reported holding BLUEBIRD BIO INC in Q2 2015. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,149,000 | -4.3% | 41,870 | -0.2% | 0.11% | -3.5% |
| Q4 2017 | $7,472,000 | +491.1% | 41,956 | +356.0% | 0.11% | +442.9% |
| Q3 2017 | $1,264,000 | -15.1% | 9,200 | +4.0% | 0.02% | -36.4% |
| Q2 2015 | $1,489,000 | +39.4% | 8,846 | 0.0% | 0.03% | +43.5% |
| Q1 2015 | $1,068,000 | – | 8,846 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bullseye Asset Management LLC | 157,872 | $5,049,000 | 1.70% |
| Sessa Capital IM, L.P. | 1,200,000 | $38,376,000 | 1.44% |
| Birchview Capital, LP | 74,000 | $2,367,000 | 1.42% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $17,211,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,836,000 | $58,715,000 | 1.05% |
| Parametrica Management Ltd | 43,412 | $1,387,000 | 1.02% |
| Tarsadia Capital, LLC | 100,000 | $3,198,000 | 0.90% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,252,575 | $40,057,000 | 0.60% |
| MANGROVE PARTNERS IM, LLC | 151,173 | $4,835,000 | 0.50% |
| Quinn Opportunity Partners LLC | 215,000 | $6,876,000 | 0.43% |